TrialThe Journal of infection2025

Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of Linezolid.

Bella Devaleenal Daniel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.